These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 15019314

  • 21. Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.
    Varma R, Hwang LJ, Grunden JW, Bean GW, Sultan MB.
    Am J Ophthalmol; 2009 Aug; 148(2):221-6. PubMed ID: 19427617
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [Abstract] [Full Text] [Related]

  • 23. 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.
    Konstas AG, Karabatsas CH, Lallos N, Georgiadis N, Kotsimpou A, Stewart JA, Stewart WC.
    Ophthalmology; 2005 Apr; 112(4):603-8. PubMed ID: 15808251
    [Abstract] [Full Text] [Related]

  • 24. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
    Higginbotham EJ, Olander KW, Kim EE, Grunden JW, Kwok KK, Tressler CS, United States Fixed-Combination Study Group.
    Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
    [Abstract] [Full Text] [Related]

  • 25. The combination latanoprost-timolol versus twice daily 0.50% timolol administration either associated or not with latanoprost: efficacy and tolerability in the primary open-angle glaucoma.
    Pacella E, Pacella F, Cavallotti C, Librando A, Feher J, Pecori-Giraldi J.
    Eur Rev Med Pharmacol Sci; 2010 May; 14(5):477-80. PubMed ID: 20556928
    [Abstract] [Full Text] [Related]

  • 26. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
    Konstas AG, Katsimbris JM, Lallos N, Boukaras GP, Jenkins JN, Stewart WC.
    Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
    [Abstract] [Full Text] [Related]

  • 27. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
    Konstas AG, Mikropoulos D, Dimopoulos AT, Moumtzis G, Nelson LA, Stewart WC.
    Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Predicting intraocular pressure change before initiating therapy: timolol versus latanoprost.
    van der Valk R, Webers CA, Hendrikse F, de Vogel SC, Prins MH, Schouten JS.
    Acta Ophthalmol; 2008 Jun; 86(4):415-8. PubMed ID: 18028236
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Configuration of the drainage angle, intraocular pressure, and optic disc cupping in subjects with chronic angle-closure glaucoma.
    Aung T, Lim MC, Chan YH, Rojanapongpun P, Chew PT, EXACT Study Group.
    Ophthalmology; 2005 Jan; 112(1):28-32. PubMed ID: 15629816
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure.
    Liu JH, Kripke DF, Weinreb RN.
    Am J Ophthalmol; 2004 Sep; 138(3):389-95. PubMed ID: 15364220
    [Abstract] [Full Text] [Related]

  • 36. A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma.
    How AC, Kumar RS, Chen YM, Su DH, Gao H, Oen FT, Ho CL, Seah SK, Aung T.
    Br J Ophthalmol; 2009 Jun; 93(6):782-6. PubMed ID: 19336424
    [Abstract] [Full Text] [Related]

  • 37. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
    Choplin N, Bernstein P, Batoosingh AL, Whitcup SM, Bimatoprost/Latanoprost Study Group.
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
    [Abstract] [Full Text] [Related]

  • 38. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M, Grigera DE, Barbosa WL, Jordao M, Susanna R.
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [Abstract] [Full Text] [Related]

  • 39. 24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol.
    Konstas AG, Pikilidou MI, Tsironi S, Mikropoulos D, Kozobolis VP, Sarafidis PA, Lasaridis AN, Nelson LA, Stewart WC.
    Curr Eye Res; 2009 May; 34(5):369-77. PubMed ID: 19401880
    [Abstract] [Full Text] [Related]

  • 40. A comparison of 0.1% timolol eye gel and 0.5% timolol eye drop in patients with chronic angle-closure glaucoma.
    Metheetrairut A, Leumsamran P, Rojananin S, Kitnarong N.
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S116-22. PubMed ID: 22696863
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.